
GK Daily Special Edition: The Vaccine We Threw Away — And Why We're Betting on It Again
Somewhere in a lab freezer in the late 1990s sat a vaccine that worked. It went through clinical trials, it earned federal approval, and it protected people from a disease that today infects roughly half a million Americans a year. Then the public turned on it, the company pulled it from pharmacy shelves, and for twenty-four years, doctors had nothing to offer except tick spray and hope. Now, one of the biggest vaccine makers on earth is trying again.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.